Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px
Document › Details

Helsinn Healthcare S.A.. (5/19/17). "Press Release: Helsinn to Present at UBS Global Healthcare Conference in New York". Lugano.

Organisations Organisation Helsinn Therapeutics (U.S.) Inc.
  Group Helsinn (Group)
  Organisation 2 UBS (Group)
Products Product UBS Global Healthcare Conference 2017 New York
  Product 2 cancer drug
Index term Index term Helsinn–UBS: investor conference, 201705 supply service Helsinn Therapeutics (U.S.) Inc presents at UBS Global Healthcare Conference NY
Persons Person Mann, William (Helsinn 201705 CEO of Helsinn Therapeutics (U.S.) Inc)
  Person 2 Bonvicini, Paola (Helsinn 201705 Group Head of Communication)

Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, announces that William Mann, Helsinn Therapeutics (U.S.), Inc, President & CEO, will present at the UBS Global Healthcare Conference on Tuesday 23rd May at 08:30am EDT at the Grand Hyatt, New York City, USA.

Mr. Mann will give a business overview of the Helsinn Group with a special focus on Helsinn’s U.S. operations.


About the Helsinn Group

Helsinn is a privately owned pharmaceutical group with an extensive portfolio of marketed cancer care products and a robust drug development pipeline. Since 1976, Helsinn has been improving the everyday lives of patients, guided by core family values of respect, integrity and quality. The Group works across pharmaceuticals, biotechnology, medical devices and nutritional supplements and has expertise in research, development, manufacture and the commercialization of therapeutic and supportive care products for cancer, pain and inflammation and gastroenterology. In 2016, Helsinn created the Helsinn Investment Fund to support early-stage investment opportunities in areas of unmet patient need. The company is headquartered in Lugano, Switzerland, with operating subsidiaries in Switzerland, Ireland and the U.S., a representative office in China as well as a product presence in approximately 190 countries globally.

Please visit

For more information please contact:

Helsinn Group
Paola Bonvicini
Group Head of Communication
Lugano, Switzerland
Tel: +41 (0) 91 985 21 21

Record changed: 2017-07-02


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

More documents for Helsinn (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top